Ignota Labs
This is a speculative internship application in the Biotechnology industry. It aims to explore potential opportunities within a company or organization, often submitted proactively without a specific position announced.
Headquarters
Cambridge, England, United Kingdom
Company Size
1-10 employees
Founded
2021
Ignota Labs is a biotech company focused on rescuing promising drugs that failed clinical trials due to safety issues. The company builds a pipeline of repurposed drug assets by leveraging its proprietary AI platform, SAFEPATH, which applies deep learning to combined bioinformatics and cheminformatics data to understand toxicity mechanisms and identify actionable solutions. By targeting drugs that stalled in preclinical or early clinical stages, Ignota Labs aims to turn them around quickly and bring safer therapeutics to patients faster than traditional drug discovery.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ignota Labs.
Ignota buys Kronos' pipeline, igniting 2nd chance salvo to rescue shelved programs
Oct 6, 2025